University of Colorado School of Public Health: National Trial - Ketamine Raises Heart Risk, No Survival Advantage Over Etomidate in Emergency Intubation
December 09, 2025
December 09, 2025
AURORA, Colorado, Dec. 9 (TNSjou) -- The University of Colorado School of Public Health issued the following news release:
* * *
National Trial: Ketamine Raises Heart Risk, No Survival Advantage Over Etomidate in Emergency Intubation
CU Anschutz researchers help lead largest U.S. randomized trial highlighting ketamine's cardiovascular risks while guiding emergency and critical care practice
*
A nationwide study by researchers . . .
* * *
National Trial: Ketamine Raises Heart Risk, No Survival Advantage Over Etomidate in Emergency Intubation
CU Anschutz researchers help lead largest U.S. randomized trial highlighting ketamine's cardiovascular risks while guiding emergency and critical care practice
*
A nationwide study by researchers . . .
